PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
PBE vs. IBB
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between PBE and IBB is 0.92, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.


-0.50.00.51.00.9

Performance

PBE vs. IBB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Invesco Dynamic Biotechnology & Genome ETF (PBE) and iShares Nasdaq Biotechnology ETF (IBB). The values are adjusted to include any dividend payments, if applicable.

350.00%400.00%450.00%500.00%550.00%600.00%JulyAugustSeptemberOctoberNovemberDecember
371.63%
514.47%
PBE
IBB

Key characteristics

Sharpe Ratio

PBE:

0.31

IBB:

0.19

Sortino Ratio

PBE:

0.56

IBB:

0.37

Omega Ratio

PBE:

1.07

IBB:

1.05

Calmar Ratio

PBE:

0.20

IBB:

0.11

Martin Ratio

PBE:

1.34

IBB:

0.73

Ulcer Index

PBE:

4.37%

IBB:

4.49%

Daily Std Dev

PBE:

18.58%

IBB:

17.65%

Max Drawdown

PBE:

-45.69%

IBB:

-62.85%

Current Drawdown

PBE:

-19.74%

IBB:

-23.93%

Returns By Period

In the year-to-date period, PBE achieves a 2.15% return, which is significantly higher than IBB's -2.03% return. Both investments have delivered pretty close results over the past 10 years, with PBE having a 3.42% annualized return and IBB not far behind at 3.29%.


PBE

YTD

2.15%

1M

-0.62%

6M

3.23%

1Y

3.91%

5Y*

3.57%

10Y*

3.42%

IBB

YTD

-2.03%

1M

-1.52%

6M

-3.18%

1Y

1.67%

5Y*

1.97%

10Y*

3.29%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


PBE vs. IBB - Expense Ratio Comparison

PBE has a 0.59% expense ratio, which is higher than IBB's 0.47% expense ratio.


PBE
Invesco Dynamic Biotechnology & Genome ETF
Expense ratio chart for PBE: current value at 0.59% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.59%
Expense ratio chart for IBB: current value at 0.47% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.47%

Risk-Adjusted Performance

PBE vs. IBB - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Invesco Dynamic Biotechnology & Genome ETF (PBE) and iShares Nasdaq Biotechnology ETF (IBB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for PBE, currently valued at 0.31, compared to the broader market0.002.004.000.310.19
The chart of Sortino ratio for PBE, currently valued at 0.56, compared to the broader market-2.000.002.004.006.008.0010.000.560.37
The chart of Omega ratio for PBE, currently valued at 1.07, compared to the broader market0.501.001.502.002.503.001.071.05
The chart of Calmar ratio for PBE, currently valued at 0.20, compared to the broader market0.005.0010.0015.000.200.11
The chart of Martin ratio for PBE, currently valued at 1.34, compared to the broader market0.0020.0040.0060.0080.00100.001.340.73
PBE
IBB

The current PBE Sharpe Ratio is 0.31, which is higher than the IBB Sharpe Ratio of 0.19. The chart below compares the historical Sharpe Ratios of PBE and IBB, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.00JulyAugustSeptemberOctoberNovemberDecember
0.31
0.19
PBE
IBB

Dividends

PBE vs. IBB - Dividend Comparison

PBE's dividend yield for the trailing twelve months is around 0.05%, less than IBB's 0.29% yield.


TTM20232022202120202019201820172016201520142013
PBE
Invesco Dynamic Biotechnology & Genome ETF
0.05%0.02%0.00%0.00%0.04%0.00%0.00%0.57%0.38%1.12%0.55%0.00%
IBB
iShares Nasdaq Biotechnology ETF
0.29%0.26%0.31%0.21%0.20%0.17%0.19%0.30%0.19%0.03%0.15%0.03%

Drawdowns

PBE vs. IBB - Drawdown Comparison

The maximum PBE drawdown since its inception was -45.69%, smaller than the maximum IBB drawdown of -62.85%. Use the drawdown chart below to compare losses from any high point for PBE and IBB. For additional features, visit the drawdowns tool.


-24.00%-22.00%-20.00%-18.00%-16.00%-14.00%JulyAugustSeptemberOctoberNovemberDecember
-19.74%
-23.93%
PBE
IBB

Volatility

PBE vs. IBB - Volatility Comparison

Invesco Dynamic Biotechnology & Genome ETF (PBE) and iShares Nasdaq Biotechnology ETF (IBB) have volatilities of 5.85% and 5.76%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


3.00%4.00%5.00%6.00%7.00%8.00%JulyAugustSeptemberOctoberNovemberDecember
5.85%
5.76%
PBE
IBB
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab